|
KMID : 0043319980210050543
|
|
Archives of Pharmacal Research
1998 Volume.21 No. 5 p.543 ~ p.548
|
|
|
Immunological Properties of Recombinant Hepatitis B Surface Antigen Expressed in Mammalian Cell(C127)
|
|
Lee Young-Soo
Kim Byung-Kak
Choi Eung-Chil
|
|
|
Abstract
|
|
|
|
We examined the immunological properties of the recombinant hepatitis B surface antigen (r-HBsAg) which was expressed in mammalian cell (C127). The cross-immunity of r-HBsAg and plasma-derived hepatitis B surface antigen (p-HBsAg) were tested using Western blotting and ELISA with guinea pig polyclonal antibody and naturally infected human-derived antibody and the both antigens show the same results in their response pattern and intensity, which indicate they have a good cross-immunity. from the measurement of after formalin- or heat-inactivation, both r-HBsAg and p-HBsAg and p-HBsAg showed $ED_{50}$ of 0.2-0.3 in formalin-inactivaton, while r-HBsAg was 0.05-0.09 and p-HBsAg was 0.03-0.07 in heat-inactivation, which means heat-inactivation method is 3-4 times superior in immunogenicity. In the immunopersistency test performed in guinea pig for the period of 3 months with two different adjuvants, antibody titer was 34.2 with muramyl dipeptide adjuvant, which was 1.8 times greater than the antibody titer of 18.9 with adjuvant. the mutagenicity of r-HBsAg has the same cross-immunity with p-HBsAg, and heat-inactivation method and muramyl dipeptide adjuvant allow development of r-HBsAg vaccine with excellent immunogenicity.
|
|
|
KEYWORD
|
|
|
Recombinant hepatitis b surface antigen (r-HBsAg), Immunological properties, plasma-derived hepatitis b surface antigen (p-HBsAg), Cross immunity, Heat inactivation
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|